Tuesday’s Pre-Market Look: Stocks In The News Before The Open

ByGary Kaltbaum

Verizon Communications (VZ) slid over 2% in pre-market trading after it reported Q4 adjusted EPS of 86 cents, weaker than consensus of 89 cents.

Alibaba (BABA) jumped almost 5% in pre-market trading after it reported Q3 revenue of 53.2 billion yuan, stronger than consensus of 50.1 billion yuan, and forecast fiscal 2017 revenue will be up 53%, higher than an earlier projection of up 48%.

Humana (HUM) was downgraded to ‘Hold’ from ‘Buy’ at Stifel.

J&J Snack Foods (JJSF) reported Q1 EPS of 72 cents, stronger than consensus of 63 cents.

HealthEquity (HQY) was rated a new ‘Overweight’ at Keybanc Capital Markets with a 12-month target price of $60.

U.S. Foods Holding Company (USFD) lost nearly 1% in after-hours trading after it launched a 30 million share secondary offering of common stock.

The Soros Fund increased its passive stake in Sigma Designs (SIGM) to 5.3% from 3.11%.

Enterprise Financial Services (EFSC) reported Q4 core EPS of 59 cents, below consensus of 61 cents.

Brown & Brown (BRO) reported Q4 adjusted EPS of 42 cents, above consensus of 41 cents.

Yahoo! (YHOO) gained almost 1% in after-hours trading after it reported Q4 adjusted EPS of 25 cents, higher than consensus of 21 cents.

Ocular Therapeutix (OCUL) slid over 5% in after-hours trading after it announced a $25 million public offering of common stock.

Mercury Systems (MRCY) jumped 8% in after-hours trading after it reported Q2 adjusted EPS of 30 cents, better than consensus of 26 cents, and said is it sees Q3 adjusted EPS of 29 cents-32 cents, above consensus of 29 cents.

Fortina Silver Mines (FSM) dropped 6% in after-hours trading after it issued 10.32 million shares at $6.30 per common share, an 8.7% discount to Monday’s closing price.

BioAmber (BIOA) slumped 11% in after-hours trading after it announces a $10 million underwritten public offering of common stock.

Cascadian Therapeutics (CASC) fell 4% in after-hours trading after it announced that it intends to offer and sell shares of its common stock and Series E convertible preferred stock in concurrent but separate underwritten public offerings, although no size was given.
Source: FoxBusiness, BarChart, Bloomberg, Reuters